Author

Stephan Kopp

Observed names: S. Kopp, S., Kopp

Institution: Biomay (Austria)

Observed institution: Biomay (Austria)

OpenAlex ID: A5014102787

Development of a Hypoallergenic Recombinant Parvalbumin for First-in-Man Subcutaneous Immunotherapy of Fish Allergy

2015 · Laurian Zuidmeer-Jongejan, Hans Huber, et al. · International Archives of Allergy and Immunology · 110

Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen–related apple allergy

2017 · Tamar Kinaciyan, Birgit Nagl, et al. · Journal of Allergy and Clinical Immunology · 77

Recombinant Mal d 1 facilitates sublingual challenge tests of birch pollen‐allergic patients with apple allergy

2015 · T. Kinaciyan, B. Nagl, et al. · Allergy · 19

Works count: 4

Citation count: 206

H-index: 3

I10-index: 3